The selective inhibition of IKKα presents a significant therapeutic advantage, particularly in avoiding the adverse effects and toxicity associated with IKKβ inhibition, such as inflammatory skin diseases and increased epithelial vulnerability. The gene discussed is IKBKB; the disease is inflammatory skin disease.